JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SEVERS, W. B.
Right arrow Articles by BUCKLEY, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SEVERS, W. B.
Right arrow Articles by BUCKLEY, J. P.
Journal of Pharmacology And Experimental Therapeutics, Vol. 153, Issue 3, 530-537, 1966
Copyright © 1966 by American Society for Pharmacology and Experimental Therapeutics


INTERRELATIONSHIP BETWEEN ANGIOTENSIN II AND THE SYMPATHETIC NERVOUS SYSTEM

WALTER B. SEVERS 1, ANNE E. DANIELS 1, HAROLD H. SMOOKLER 1, WILLIAM J. KINNARD 1, and JOSEPH P. BUCKLEY 1

1 Department of Pharmacology, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania

Angiotensin II (4 µg), when administered into the perfused lateral ventricle of anesthetized cats, exerted marked pressor effects which appeared to be due to activation of central nervous system structures. The data suggested that the pressor response was sympathetic in nature, involving alpha and beta adrenergic receptors and possibly adrenomedullary secretory cells. The origin of the activity did not appear to be hypothalamic, as direct injection of the peptide into the posterior hypothalamus failed to produce pressor responses. Blockade of the pressor mechanism by cerveau isolé section indicated that suprapontine structures were involved, and the failure to obtain central pressor activity by confinement of the perfusion system to the lateral and third ventricles suggested that the activity was of midbrain origin, although the possibility of bulbar afferent mechanisms cannot be excluded.

Submitted on November 29, 1965
Accepted on March 28, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics.